10x Genomics (TXG) Other financing activities (2018 - 2026)

10x Genomics has disclosed Other financing activities across 9 years of filings, most recently posting $3.0 million for Q2 2026.

• In Q2 2026, Other financing activities fell 14.37% year-over-year to $3.0 million; the TTM figure through Jun 2026 stood at $6.1 million (down 28.65% YoY), while the FY2025 annual figure was $6.8 million, down 37.67% from the prior year.
• Other financing activities came in at $3.0 million for Q2 2026 at 10x Genomics, up from $273000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $7.8 million in Q1 2022 to a low of $156000.0 in Q3 2024.
• Average Other financing activities over 5 years is $3.4 million, with a median of $3.6 million recorded in 2023.
• Year-over-year, Other financing activities sank 96.43% in 2024 and surged 295.51% in 2025.
• Over 5 years, Other financing activities stood at $5.0 million in 2022, then climbed by 12.24% to $5.6 million in 2023, then dropped by 19.53% to $4.5 million in 2024, then tumbled by 50.37% to $2.2 million in 2025, then soared by 34.52% to $3.0 million in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $3.0 million in Q2 2026, $273000.0 in Q1 2026, and $2.2 million in Q4 2025.